Advisor Group Holdings, Inc. Alaunos Therapeutics, Inc. Transaction History

Advisor Group Holdings, Inc.

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	SELL	$0.04 - $0.13 $2,971 - $9,656	-74,279 Reduced 11.77%	556,666 $38,000
Q3 2023 Nov 13, 2023	BUY	$0.12 - $0.5 $2,448 - $10,200	20,400 Added 3.34%	630,945 $82,000
Q2 2023 Aug 10, 2023	SELL	$0.43 - $0.65 $774 - $1,170	-1,800 Reduced 0.29%	610,545 $311,000
Q1 2023 May 12, 2023	BUY	$0.46 - $0.81 $27,653 - $48,693	60,116 Added 10.89%	612,345 $385,000
Q4 2022 Feb 10, 2023	SELL	$0.5 - $261.0 $15,255 - $7.96 Million	-30,511 Reduced 5.24%	552,229 $358,000
Q3 2022 Nov 14, 2022	BUY	$1.04 - $322.5 $5,586 - $1.73 Million	5,372 Added 0.93%	582,740 $1 Million
Q2 2022 Aug 10, 2022	BUY	$0.41 - $1.24 $3,932 - $11,892	9,591 Added 1.69%	577,368 $716,000
Q1 2022 May 04, 2022	BUY	$0.62 - $1.17 $73,651 - $138,987	118,793 Added 26.46%	567,777 $452,000
Q3 2021 Nov 05, 2021	BUY	$1.44 - $2.73 $151,961 - $288,094	105,529 Added 30.73%	448,984 $817,000
Q2 2021 Aug 02, 2021	SELL	$2.63 - $3.67 $6,482 - $9,046	-2,465 Reduced 0.71%	343,455 $906,000
Q1 2021 May 13, 2021	BUY	$2.82 - $5.6 $198,657 - $394,497	70,446 Added 25.57%	345,920 $1.25 Million
Q4 2020 Feb 10, 2021	BUY	$2.09 - $3.09 $187,312 - $276,935	89,623 Added 48.22%	275,474 $694,000
Q3 2020 Nov 12, 2020	SELL	$2.39 - $3.43 $17,069 - $24,497	-7,142 Reduced 3.7%	185,851 $469,000
Q2 2020 Aug 14, 2020	BUY	$2.2 - $3.71 $103,690 - $174,859	47,132 Added 32.31%	192,993 $633,000
Q1 2020 May 18, 2020	BUY	$1.9 - $4.98 $277,135 - $726,387	145,861 New	145,861 $367,000

92.6K

Ticker TCRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,182,000
Market Cap $458M
Description
Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.